|
It was reported that the bd syringe 1ml s/t w/ndl 27x3/8 ib needle went through the shield.The following information was provided by the initial reporter: material#: 303344, batch#: 3117445.Rcc received a complaint via email.Two different 1ml (27g) tb syringes were defective in the same lot.One syringe, had the needle bent and was completely exposed outside the cap (the needle went through the side of the cap) in the secured package.The other syringe had the needle slightly bent (it did not pierce the cap) however, the actual cap was broken and didn't fit securely over the needle.The syringes were never exposed to the patient - the defects were identified before pt contact occurred.
|
|
(b)(4).Follow up for device evaluation.It was reported that one needle was bent and completely exposed outside the cap within the secured package, while the other needle was slightly bent but did not pierce the cap.Additionally, the cap itself was broken and did not fit securely over the needle.To support the investigation, one sample in an opened blister package, assembled to a 1ml syringe, was received for evaluation by the quality team.A visual inspection was performed, and the needle assembly showed no defects or imperfections.The needle was straight, and the plastic shield exhibited no damage.A review of the device history record was completed for material number 303344, batch 3117445.The review confirmed that all visual inspections were performed according to requirements, with no quality notifications related to the reported condition.The lot was inspected and accepted based on the inspection control plan and subsequently approved for shipment.Additional device history records were reviewed for each batch of needles used in manufacturing this final batch, and no documentation indicated this type of defect during the entire production run.To date, no similar events have been reported for this lot.Based on the investigation and analysis of the returned sample, the reported issue could not be confirmed.
|